These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7329845)

  • 1. [Effect of hemoperfusion on various blood coagulation and fibrinolysis factors in chronic uremia].
    Lewicki R; Trznadel K; Luciak M; Kidawa Z
    Pol Tyg Lek; 1981 Aug; 36(35):1325-7. PubMed ID: 7329845
    [No Abstract]   [Full Text] [Related]  

  • 2. [A comparison of the efficiency of eliminating middle-weight molecules and myoinositol from plasma during hemoperfusion and hemodialysis in cases of chronic uremia].
    Trznadel K; Kidawa Z; Walasek L; Lutz W
    Pol Tyg Lek; 1978 Feb; 33(7):257-9. PubMed ID: 758030
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
    Popławski A; Myśliwiec M; Soszka J
    Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):810-3. PubMed ID: 2096374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of haemostasis in fifteen uraemic patients subjected to chronic haemodialysis (author's transl)].
    Barrantes Boulanger A; Soto Quirós M; Salas González R
    Sangre (Barc); 1980; 25(3):289-99. PubMed ID: 7414445
    [No Abstract]   [Full Text] [Related]  

  • 5. [Activation of blood platelets and the plasma coagulation system in patients with chronic uremia].
    Dmoszyńska-Giannopoulou A; Ksiazek A; Baran E; Pachucki Z
    Pol Tyg Lek; 1987 Jul; 42(30):915-7. PubMed ID: 3671183
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemoperfusion results in uremia.
    Gelfand MC; Winchester JF
    Clin Nephrol; 1979 Feb; 11(2):107-10. PubMed ID: 378488
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessments of clinical trials of charcoal hemoperfusion in uremic patients.
    Chang TM
    Clin Nephrol; 1979 Feb; 11(2):111-9. PubMed ID: 378489
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of hemoperfusion on plasma oxidizing capacity and erythrocyte sensitivity to oxidation in patients with chronic uremia].
    Trznadel K; Luciak M; Mamczur D; Kroczak M; Zbróg Z; Kidawa Z
    Pol Tyg Lek; 1989 Feb; 44(9):226-8. PubMed ID: 2813185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoperfusion in chronic uremia.
    Stefoni S; Feliciangeli G; Cianciolo G; De Sanctis LB; Giardino R; Spighi M
    Boll Soc Ital Biol Sper; 1993 Nov; 69(11):675-82. PubMed ID: 8060597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adequacy of hemoperfusion for blood purification in uremia.
    Chang TM
    Contrib Nephrol; 1993; 103():10-25. PubMed ID: 8354053
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of different types of substitutive treatment on fibrinolytic potential of chronic uremic patients].
    Canavese C; Stratta P; Mangiarotti G; Triolo G; Bagnis C; Racca M; Vercellone A
    Minerva Nefrol; 1981; 28(3):339-43. PubMed ID: 7329613
    [No Abstract]   [Full Text] [Related]  

  • 12. First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta(2)-microglobulin in hemodialysis.
    Ronco C; Brendolan A; Winchester JF; Golds E; Clemmer J; Polaschegg HD; Muller TE; La Greca G ; Levin NW
    Blood Purif; 2001; 19(2):260-3. PubMed ID: 11150821
    [No Abstract]   [Full Text] [Related]  

  • 13. Impaired fibrinolysis in uremia: partial and variable correction by four different dialysis regimes.
    Canavese C; Stratta P; Pacitti A; Mangiarotti G; Racca M; Oneglio R; Vercellone A
    Clin Nephrol; 1982 Feb; 17(2):82-9. PubMed ID: 7067170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of extracorporeal hemodialysis on some aspects of hemostatic function in chronic uremia].
    Cocconi G; Ferioli V; Franchini I
    Minerva Nefrol; 1967; 14(4):162-8. PubMed ID: 5304654
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemoperfusion for uremia: past, present, and future.
    Winchester JF; Ash SR
    Kidney Int Suppl; 1985 Dec; 17():S127-30. PubMed ID: 3867782
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adsorbents in the treatment of uremia. Hemoperfusion plus hemodialysis].
    Stalteri A; Rapisarda LM; Battiati E; Galione A; Picone F; Falco M; Romano M
    Minerva Nefrol; 1979; 26(2):217-20. PubMed ID: 471354
    [No Abstract]   [Full Text] [Related]  

  • 17. [Programmed use of hemoperfusion through activated charcoal in treatment of patients with terminal uremia].
    Levitskiĭ ER; Dmitriev AA; Pliaskina AV
    Ter Arkh; 1977; 49(7):61-4. PubMed ID: 898078
    [No Abstract]   [Full Text] [Related]  

  • 18. The spreading ability of platelets in chronic uraemia.
    Berkessy S; Faludi AG
    Ann Clin Res; 1974 Feb; 6(1):65-7. PubMed ID: 4544909
    [No Abstract]   [Full Text] [Related]  

  • 19. Removal of phosphate either by bicarbonate dialysis or biofiltration in uremics.
    Bazzato G; Coli U; Landini S; Fracasso A; Righetto F; Scanferla F; Morachiello P
    Kidney Int Suppl; 1988 Mar; 24():S180-3. PubMed ID: 3163046
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of bleeding in dialysis patients.
    Galbusera M; Remuzzi G; Boccardo P
    Semin Dial; 2009; 22(3):279-86. PubMed ID: 19573008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.